Sullivan Christopher Ryan
Insider CIK 1810417 · AVTX Interim CFO
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| AVTX Avalo Therapeutics, Inc. | M Exercise deriv | 2026-09-16 | 2026-09-18 | 12,394 | — | $0 | 83,848 | SEC↗ |
| AVTX Avalo Therapeutics, Inc. | S Sale | 2026-09-16 | 2026-09-18 | 12,394 | $16.33 | $202.4K | 39,900 | SEC↗ |
| AVTX Avalo Therapeutics, Inc. | M Exercise | 2026-09-16 | 2026-09-18 | 12,394 | $9.88 | $122.5K | 52,294 | SEC↗ |
| AVTX Avalo Therapeutics, Inc. | M Exercise deriv | 2026-09-16 | 2026-09-18 | 12,394 | — | $0 | 83,848 | SEC↗ |
| AVTX Avalo Therapeutics, Inc. | S Sale | 2026-09-16 | 2026-09-18 | 12,394 | $16.33 | $202.4K | 39,900 | SEC↗ |
| AVTX Avalo Therapeutics, Inc. | M Exercise | 2026-09-16 | 2026-09-18 | 12,394 | $9.88 | $122.5K | 52,294 | SEC↗ |
| AVTX Avalo Therapeutics, Inc. | M Exercise deriv | 2026-09-10 | 2026-09-11 | 10,185 | — | $0 | 105,815 | SEC↗ |
| AVTX Avalo Therapeutics, Inc. | S Sale | 2026-09-10 | 2026-09-11 | 10,185 | $17.62 | $179.5K | 39,900 | SEC↗ |
| AVTX Avalo Therapeutics, Inc. | M Exercise | 2026-09-10 | 2026-09-11 | 10,185 | $8.04 | $81.9K | 50,085 | SEC↗ |
| AVTX Avalo Therapeutics, Inc. | M Exercise deriv | 2026-09-10 | 2026-09-11 | 10,185 | — | $0 | 105,815 | SEC↗ |
| AVTX Avalo Therapeutics, Inc. | S Sale | 2026-09-10 | 2026-09-11 | 10,185 | $17.62 | $179.5K | 39,900 | SEC↗ |
| AVTX Avalo Therapeutics, Inc. | M Exercise | 2026-09-10 | 2026-09-11 | 10,185 | $8.04 | $81.9K | 50,085 | SEC↗ |
| AVTX Avalo Therapeutics, Inc. | M Exercise deriv | 2026-08-18 | 2026-08-19 | 31,031 | — | $0 | 96,242 | SEC↗ |
| AVTX Avalo Therapeutics, Inc. | M Exercise | 2026-08-18 | 2026-08-19 | 31,031 | $9.88 | $306.6K | 70,931 | SEC↗ |
| AVTX Avalo Therapeutics, Inc. | S Sale | 2026-08-18 | 2026-08-19 | 31,031 | $20.05 | $622.2K | 39,900 | SEC↗ |
| AVTX Avalo Therapeutics, Inc. | M Exercise deriv | 2026-08-18 | 2026-08-19 | 31,031 | — | $0 | 96,242 | SEC↗ |
| AVTX Avalo Therapeutics, Inc. | S Sale | 2026-08-18 | 2026-08-19 | 31,031 | $20.05 | $622.3K | 39,900 | SEC↗ |
| AVTX Avalo Therapeutics, Inc. | M Exercise | 2026-08-18 | 2026-08-19 | 31,031 | $9.88 | $306.6K | 70,931 | SEC↗ |
| AVTX Avalo Therapeutics, Inc. | M Exercise deriv | 2026-08-17 | 2026-08-19 | 2,876 | — | $0 | 127,273 | SEC↗ |
| AVTX Avalo Therapeutics, Inc. | M Exercise deriv | 2026-08-17 | 2026-08-19 | 37,945 | — | $0 | 130,149 | SEC↗ |
| AVTX Avalo Therapeutics, Inc. | M Exercise | 2026-08-17 | 2026-08-19 | 37,945 | $9.88 | $374.9K | 78,718 | SEC↗ |
| AVTX Avalo Therapeutics, Inc. | M Exercise | 2026-08-17 | 2026-08-19 | 2,876 | $9.88 | $28.4K | 81,594 | SEC↗ |
| AVTX Avalo Therapeutics, Inc. | S Sale | 2026-08-17 | 2026-08-19 | 37,945 | $19.85 | $753.2K | 43,649 | SEC↗ |
| AVTX Avalo Therapeutics, Inc. | S Sale | 2026-08-17 | 2026-08-19 | 3,749 | $19.94 | $74.8K | 39,900 | SEC↗ |
| AVTX Avalo Therapeutics, Inc. | M Exercise deriv | 2026-08-17 | 2026-08-19 | 2,876 | — | $0 | 127,273 | SEC↗ |
| AVTX Avalo Therapeutics, Inc. | M Exercise deriv | 2026-08-17 | 2026-08-19 | 37,945 | — | $0 | 130,149 | SEC↗ |
| AVTX Avalo Therapeutics, Inc. | S Sale | 2026-08-17 | 2026-08-19 | 3,749 | $19.94 | $74.8K | 39,900 | SEC↗ |
| AVTX Avalo Therapeutics, Inc. | S Sale | 2026-08-17 | 2026-08-19 | 37,945 | $19.85 | $753.3K | 43,649 | SEC↗ |
| AVTX Avalo Therapeutics, Inc. | M Exercise | 2026-08-17 | 2026-08-19 | 2,876 | $9.88 | $28.4K | 81,594 | SEC↗ |
| AVTX Avalo Therapeutics, Inc. | M Exercise | 2026-08-17 | 2026-08-19 | 37,945 | $9.88 | $374.9K | 78,718 | SEC↗ |
| AVTX Avalo Therapeutics, Inc. | F Tax w/h | 2026-06-10 | 2026-06-12 | 138 | $13.10 | $1.8K | 40,773 | SEC↗ |
| AVTX Avalo Therapeutics, Inc. | A Award | 2026-05-21 | 2026-05-26 | 39,900 | — | $0 | 40,323 | SEC↗ |
| AVTX Avalo Therapeutics, Inc. | M Exercise deriv | 2026-05-07 | 2026-05-11 | 18,606 | — | $0 | 168,094 | SEC↗ |
| AVTX Avalo Therapeutics, Inc. | M Exercise | 2026-05-07 | 2026-05-11 | 18,606 | $9.88 | $183.8K | 19,029 | SEC↗ |
| AVTX Avalo Therapeutics, Inc. | S Sale | 2026-05-07 | 2026-05-11 | 18,606 | $24.12 | $448.8K | 423 | SEC↗ |
| AVTX Avalo Therapeutics, Inc. | M Exercise deriv | 2026-05-06 | 2026-05-07 | 47,000 | — | $0 | 116,000 | SEC↗ |
| AVTX Avalo Therapeutics, Inc. | M Exercise | 2026-05-06 | 2026-05-07 | 47,000 | $8.04 | $377.9K | 47,423 | SEC↗ |
| AVTX Avalo Therapeutics, Inc. | S Sale | 2026-05-06 | 2026-05-07 | 13,834 | $18.55 | $256.6K | 33,589 | SEC↗ |
| AVTX Avalo Therapeutics, Inc. | S Sale | 2026-05-06 | 2026-05-07 | 8,900 | $22.57 | $200.9K | 423 | SEC↗ |
| AVTX Avalo Therapeutics, Inc. | S Sale | 2026-05-06 | 2026-05-07 | 12,347 | $19.28 | $238.1K | 21,242 | SEC↗ |
| AVTX Avalo Therapeutics, Inc. | S Sale | 2026-05-06 | 2026-05-07 | 2,700 | $20.76 | $56.1K | 18,542 | SEC↗ |
| AVTX Avalo Therapeutics, Inc. | S Sale | 2026-05-06 | 2026-05-07 | 9,219 | $21.37 | $197.0K | 9,323 | SEC↗ |
| AVTX Avalo Therapeutics, Inc. | S Sale | 2026-04-30 | 2026-05-01 | 8,457 | $13.23 | $111.9K | 423 | SEC↗ |
| AVTX Avalo Therapeutics, Inc. | S Sale | 2026-04-29 | 2026-05-01 | 8,458 | $13.09 | $110.7K | 8,880 | SEC↗ |
| AVTX Avalo Therapeutics, Inc. | S Sale | 2026-04-02 | 2026-04-03 | 6,200 | $17.02 | $105.5K | 19,118 | SEC↗ |
| AVTX Avalo Therapeutics, Inc. | S Sale | 2026-04-02 | 2026-04-03 | 1,780 | $17.57 | $31.3K | 17,338 | SEC↗ |
| AVTX Avalo Therapeutics, Inc. | S Sale | 2026-04-01 | 2026-04-03 | 500 | $15.86 | $7.9K | 32,797 | SEC↗ |
| AVTX Avalo Therapeutics, Inc. | S Sale | 2026-04-01 | 2026-04-03 | 7,479 | $16.83 | $125.9K | 25,318 | SEC↗ |
| AVTX Avalo Therapeutics, Inc. | M Exercise deriv | 2026-03-28 | 2026-03-31 | 24,200 | — | $0 | 24,200 | SEC↗ |
| AVTX Avalo Therapeutics, Inc. | M Exercise | 2026-03-28 | 2026-03-31 | 24,200 | — | $0 | 41,538 | SEC↗ |
| AVTX Avalo Therapeutics, Inc. | F Tax w/h | 2026-03-28 | 2026-03-31 | 8,241 | $13.89 | $114.5K | 33,297 | SEC↗ |
| AVTX Avalo Therapeutics, Inc. | A Award deriv | 2026-02-26 | 2026-03-02 | 105,000 | — | $0 | 105,000 | SEC↗ |
| AVTX Avalo Therapeutics, Inc. | F Tax w/h | 2025-12-10 | 2025-12-12 | 155 | $4.10 | $636 | 17,338 | SEC↗ |
| AVTX Avalo Therapeutics, Inc. | M Exercise deriv | 2025-03-28 | 2025-04-01 | 24,200 | — | $0 | 48,400 | SEC↗ |
| AVTX Avalo Therapeutics, Inc. | M Exercise | 2025-03-28 | 2025-04-01 | 24,200 | — | $0 | 24,206 | SEC↗ |
| AVTX Avalo Therapeutics, Inc. | F Tax w/h | 2025-03-28 | 2025-04-01 | 7,285 | $8.46 | $61.6K | 16,921 | SEC↗ |
| AVTX Avalo Therapeutics, Inc. | A Award deriv | 2025-01-28 | 2025-01-30 | 163,000 | — | $0 | 163,000 | SEC↗ |
| AVTX Avalo Therapeutics, Inc. | A Award deriv | 2024-08-13 | 2024-08-14 | 72,600 | — | $0 | 72,600 | SEC↗ |
| AVTX Avalo Therapeutics, Inc. | A Award deriv | 2024-08-13 | 2024-08-14 | 186,700 | — | $0 | 186,700 | SEC↗ |
| AVTX Avalo Therapeutics, Inc. | P Buy | 2023-06-09 | 2023-06-13 | 511 | $3.42 | $1.7K | 1,262 | SEC↗ |
| AVTX Avalo Therapeutics, Inc. | A Award deriv | 2023-05-15 | 2023-05-17 | 40,000 | — | $0 | 40,000 | SEC↗ |
| AVTX Avalo Therapeutics, Inc. | A Award deriv | 2023-02-13 | 2023-02-15 | 40,000 | — | $0 | 40,000 | SEC↗ |
| AVTX Avalo Therapeutics, Inc. | A Award deriv | 2022-10-05 | 2022-10-07 | 25,000 | — | $0 | 25,000 | SEC↗ |
| AVTX Avalo Therapeutics, Inc. | A Award deriv | 2022-03-08 | 2022-03-10 | 50,000 | — | $0 | 50,000 | SEC↗ |
| AVTX Avalo Therapeutics, Inc. | A Award deriv | 2022-03-08 | 2022-03-10 | 400,000 | — | $0 | 400,000 | SEC↗ |
| AVTX Avalo Therapeutics, Inc. | P Buy | 2021-12-10 | 2021-12-14 | 955 | $1.57 | $1.5K | 9,004 | SEC↗ |
| CERC Cerecor Inc. | A Award deriv | 2021-01-26 | 2021-01-28 | 110,000 | — | $0 | 110,000 | SEC↗ |
| CERC Cerecor Inc. | P Buy | 2020-12-10 | 2020-12-14 | 5,095 | $2.28 | $11.6K | 8,049 | SEC↗ |
| CERC Cerecor Inc. | P Buy | 2020-06-10 | 2020-06-11 | 2,954 | $2.28 | $6.7K | 2,954 | SEC↗ |